| Literature DB >> 30906785 |
Fatima A I Al-Khodir1, Hana M A Abumelha1, Tarfah Al-Warhi1, S A Al-Issa1.
Abstract
New Pd(II) andEntities:
Mesh:
Substances:
Year: 2019 PMID: 30906785 PMCID: PMC6398043 DOI: 10.1155/2019/9835745
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Structures of prepared triazine ligands [29].= N-(4-chlorophenyl)-N,N-di(pyrimidin-2-yl)-1,3,5-triazine-2,4,6-triamine.= N-(4-chlorophenyl)-N,N-di(pyrimidin-2-yl)-1,3,5-triazine-2,4,6-triamine.=6-chloro-N-(pyrimidin-2-yl)-N-(1H-1,2,4-triazol-3-yl)-1,3,5-triazine-2,4-diamine.= 6-chloro-N-(4-chlorophenyl)-N-(pyrimidin-2-yl)-1,3,5-triazine-2,4-diamine).
Figure 2Synthesis of trisubstituted triazine derivatives.
Microanalytical and physicochemical data of ligands and their complexes.
| Compounds | Color | Λ( | Elemental analyses found(Calc.) | Yield, % | |||
|---|---|---|---|---|---|---|---|
| %C | %H | %N | %M | ||||
|
| Yellow | 126.8 | (21.44) | (2.01) | (14.71) | (30.73) | 77 |
| 21.32 | 1.96 | 14.57 | 30.66 | ||||
|
| |||||||
|
| Brown | 70.6 | (20.66) | (1.63) | (13.55) | (31.46) | 72 |
| 20.54 | 1.54 | 13.50 | 31.32 | ||||
|
| |||||||
|
| Green | 64.7 | (13.13) | (1.22) | (17.02) | (35.55) | 71 |
| 13.09 | 1.18 | 17.00 | 35.50 | ||||
|
| |||||||
|
| Pale yellow | 95.6 | (22.64) | (2.19) | (14.22) | (28.29) | 69 |
| 22.56 | 2.13 | 14.16 | 28.11 | ||||
|
| |||||||
|
| Dark brown | 139.3 | (28.64) | (2.69) | (19.65) | (22.39) | 75 |
| 28.56 | 2.57 | 19.54 | 22.31 | ||||
|
| |||||||
|
| Red brown | 82 | (26.77) | (2.53) | (17.56) | (22.24) | 70 |
| 26.71 | 2.51 | 17.49 | 22.19 | ||||
|
| |||||||
|
| Brownish green | 106.7 | (17.70) | (2.15) | (22.94) | (26.14) | 74 |
| 17.65 | 2.09 | 22.90 | 26.11 | ||||
|
| |||||||
|
| Brown | 122.3 | (30.49) | (2.56) | (19.15) | (20.78) | 71 |
| 30.41 | 2.49 | 19.12 | 20.69 | ||||
∗ [Pt3(L)2(Cl)9(H2O)3].3Cl.3H2O (1), [Pt3(L)2(Cl)9(H2O)3].3Cl (2), [Pt3(L)2(Cl)9(H2O)3].3Cl (3), [Pt2(L)2(Cl)6(H2O)2] .2Cl.4H2O (4), [Pd3(L)2(H2O)6].3Cl2 (5), [Pd3(L)2(H2O)6].3Cl2 (6), [Pd3(L)2(H2O)6] .3Cl2 (7) and [Pd2(L)2(H2O)4].2Cl2 (8).
Figure 3Suggested structures of Pt(IV) and Pd(II) complexes.
FT-IR spectral band assignments of L, L, L, and L ligands and their complexes.
| Compounds | FTIR spectral assignments (cm−1) | ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
|
| 3249-3112 | 1623 | 1559 | 1488 | - |
|
| |||||
|
| 3260-3142 | 1619 | 1555 | 1485 | - |
|
| |||||
|
| 3251-3156 | 1621 | 1586 | 1510 | - |
|
| |||||
|
| 3244-3150 | 1619 | 1574 | 1484 | - |
|
| |||||
|
| 3200 | 1679 | 1560 | 1385 | 545, 447 |
|
| |||||
|
| - | 1667 | 1537 | 1383 | 536, 441 |
|
| |||||
|
| - | 1698 | 1585 | 1382 | 570, 470 |
|
| |||||
|
| - | 1695 | 1567 | 1390 | 530, 469 |
|
| |||||
|
| - | 1689 | 1530 | 1394 | 537, 440 |
|
| |||||
|
| - | 1695 | 1557 | 1396 | 540, 463 |
|
| |||||
|
| - | 1698 | 1550 | 1391 | 537, 467 |
|
| |||||
|
| - | 1691 | 1537 | 1393 | 537, 463 |
Figure 4FT-IR spectra of (a) [Pt2(L)2(Cl)6(H2O)2].2Cl.4H2O (4) and (b) [Pd3(L)2 (H2O)6].3Cl2 (6).
Figure 5TGA-DTG curves of Pt(IV) complexes 1–4.
Figure 6TGA-DTG curves of Pd(II) complexes 5–8.
Thermo gravimetric data of Pt(IV) and Pd(II) triazine complexes.
| Complexes | DTGmax | Total weight loss | Total residual | ||
|---|---|---|---|---|---|
| Weight loss, % | Assignments | Residue, % | Assignments | ||
|
| 100 | 74 | 3H2O uncoord | 26 | PtO2 + Few carbons |
| 300, 380, 600 | 2 | ||||
|
| |||||
|
| 100 | 70 | 3H2O coord | 30 | PtO2 + Few carbons |
| 310, 380, 580 | 2 | ||||
|
| |||||
|
| 100 | 68 | 3H2O coord | 32 | PtO2 + Few carbons |
| 370, 580, 700 | 2 | ||||
|
| |||||
|
| 100 | 72 | 4H2O uncoord | 28 | PtO2 + Few carbons |
| 280, 380, 700 | 2 | ||||
|
| |||||
|
| 230, 360, 620 | 75 | 2 | 25 | PdO + Few carbons |
|
| |||||
|
| 360, 420, 800 | 75 | 2 | 25 | PdO + Few carbons |
|
| |||||
|
| 300, 360, 650 | 78 | 2 | 22 | PdO + Few carbons |
|
| |||||
|
| 380, 620, 800 | 82 | 2 | 18 | PdO + Few carbons |
Figure 7
Figure 8SEM photos of Pt(IV) and Pd(II) complexes 1–8.
Figure 9TEM photos of Pt(IV) complexes 1–4.
Inhibition zone diameter of free ligands and its Pt(IV) and Pd(II) complexes.
| Sample | Inhibition zone diameter (mm/mg Sample) | ||||
|---|---|---|---|---|---|
| Bacteria | Fungi | ||||
|
|
|
|
| ||
| Standard | Ampicillin: Antibacterial agent | 30 | 24 | -- | -- |
| Amphotericin B: Antifungal agent | -- | -- | 16 | 21 | |
|
| |||||
| Control: DMSO | 0.0 | 0.0 | 0.0 | 0.0 | |
|
| |||||
|
| 11 | 10 | 10 | 0.0 | |
|
| |||||
|
| 0.0 | 0.0 | 0.0 | 0.0 | |
|
| |||||
|
| 0.0 | 0.0 | 0.0 | 0.0 | |
|
| |||||
|
| 15 | 10 | 0.0 | 0.0 | |
|
| |||||
|
| 19 | 18 | 16 | 0.0 | |
|
| |||||
|
| 12 | 11 | 0.0 | 0.0 | |
|
| |||||
|
| 24 | 23 | 12 | 0.0 | |
|
| |||||
|
| 14 | 12 | 0.0 | 0.0 | |
|
| |||||
|
| 14 | 15 | 15 | 0.0 | |
|
| |||||
|
| 11 | 11 | 0.0 | 0.0 | |
|
| |||||
|
| 16 | 17 | 12 | 0.0 | |
|
| |||||
|
| 14 | 15 | 11 | 0.0 | |
∗Ampicillin and amphotericin B are standards of antibacterial and antifungal agents.
IC50 activity of the free ligands and its Pt(IV) complexes.
| Against human colon cancer cell lines | ||||||||
|
| ||||||||
| Concentration ( | Viability (%) | |||||||
|
|
|
|
|
|
|
|
| |
|
| ||||||||
| 100 | 65 | 66 | 61 | 72.7 | 55.3 | 6.4 | 35.5 | 44.6 |
|
| ||||||||
| 50 | 70 | 67.8 | 64.4 | 81.7 | 60 | 31.8 | 41.4 | 56.6 |
|
| ||||||||
| 10 | 72 | 70 | 69.3 | 82.5 | 65 | 62.9 | 66.8 | 71.5 |
|
| ||||||||
| IC50 | 170 | 461 | 277 | 259 | 162.8 | 27 | 50.7 | 79 |
|
| ||||||||
| Against human lung cancer A549 cell lines | ||||||||
|
| ||||||||
| Concentration ( | Viability (%) | |||||||
|
|
|
|
|
|
|
|
| |
|
| ||||||||
| 150 | 82.4 | 100 | 96 | 100 | 100 | 44.6 | 100 | 77.7 |
|
| ||||||||
| 100 | 83.4 | 100 | 98.7 | 100 | 100 | 61.7 | 100 | 100 |
|
| ||||||||
| 50 | 86 | 100 | 100 | 100 | 100 | 66.5 | 100 | 100 |
|
| ||||||||
| 10 | 98.7 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
|
| ||||||||
| IC50 | 431.4 | - | 1305.7 | - | - | 128 | - | 212 |
Figure 10| No. | Type of analysis | Model of the instruments |
| (i) | Elemental analyses | Perkin Elmer CHN 2400 (USA) |
| (ii) | Metal ions | gravimetrically |
| (iii) | Melting point | MPS10–120 |
| (iv) | Molar conductivities | Jenway 4010 conductivity meter |
| (v) | Infrared spectra | Bruker Alpha FTIR Spectrophotometer |
| (vi) | UV-Vis absorption spectra | UV2 Unicam UV/Vis Spectrophotometer |
| (vii) | Magnetic moments | Magnetic Susceptibility Balance, Sherwood Scientific, Cambridge Science Park, Cambridge, England |
| (viii) | 1H,13C-NMR spectra | Oxford YH-300 NMR spectrometer |
| (ix) | Mass spectra | 70 eV using AEI MS 30 mass spectrometer |
| (x) | Thermal studies TG/DTG | Mettler Toledo AG thermogravimetric analyzer |
| (xi) | SEM | Quanta FEG 250 equipment |
| (xii) | XRD | X 'Pert PRO PANanalytical X-ray powder diffraction |
| (xiii) | TEM | JEOL 100s microscopy |